Barry Lubarsky
About Barry Lubarsky
Barry Lubarsky is the Vice President of Medical Affairs Strategy at Alkermes in Waltham, Massachusetts, with extensive experience in medical affairs and a strong academic background in biochemistry.
Current Role at Alkermes
Barry Lubarsky holds the position of Vice President, Medical Affairs Strategy at Alkermes. Based in Waltham, Massachusetts, he plays a pivotal role in shaping the medical affairs strategy for the company. His expertise in the field helps drive forward scientific initiatives and strategic planning for the organization's medical affairs operations.
Career History at Alkermes
Barry Lubarsky has been with Alkermes since 2017 and has held multiple key roles in the company. Starting as Senior Medical Director, Medical Affairs, he was later promoted to Executive Director, Medical Affairs Strategy, and now serves as Vice President, Medical Affairs Strategy. His tenure at Alkermes has seen him contribute significantly to the medical affairs strategy and development projects.
Previous Experience at Vertex Pharmaceuticals
Before joining Alkermes, Barry Lubarsky worked at Vertex Pharmaceuticals for a total of 9 years. He served as Director, Medical Affairs from 2008 to 2014 and was later promoted to Senior Director, Medical Affairs (NA), a position he held until 2017. His time at Vertex allowed him to gain extensive experience with both biologic and small molecule drugs in orphan disease areas, at both US and global levels.
Education in Biochemistry
Barry Lubarsky has a strong academic background in Biochemistry. He achieved a PhD from Stanford University School of Medicine, where he studied from 1996 to 2003. Prior to this, he studied Biochemistry at the University of Cambridge for one year, and completed his BA in Biochemistry at the University of Pennsylvania from 1991 to 1995. His academic training has equipped him with deep subject-matter expertise.
Roles in Medical Affairs
Throughout his career, Barry Lubarsky has held various significant roles in medical affairs. He was the Senior Director, Medical Affairs at Ocular Therapeutix, Inc. for a brief period in 2017, and the Deputy Director, Medical & Publication Strategy at Bayer HealthCare Pharmaceuticals from 2005 to 2008. He also worked as Medical Director at Helix Medical Communications from 2003 to 2005, gaining diverse experience in the industry.